Your browser doesn't support javascript.
loading
Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy.
Kyvsgaard, Emil R; Riley, Caroline; Clausen, Michael Roost; Harsløf, Mads; Heftdal, Line Dam; Niemann, Carsten U; Grønbaek, Kirsten; Hutchings, Martin; Husby, Simon.
Afiliação
  • Kyvsgaard ER; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Riley C; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark.
  • Clausen MR; Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark.
  • Harsløf M; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Heftdal LD; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark.
  • Niemann CU; Department of Hematology, Vejle University Hospital, Vejle, Denmark.
  • Grønbaek K; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Hutchings M; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark.
  • Husby S; Viro-immunology Research Unit, Department of Infectious Diseases, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Br J Haematol ; 204(1): 356-360, 2024 01.
Article em En | MEDLINE | ID: mdl-37830381

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Anticorpos Biespecíficos / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Anticorpos Biespecíficos / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article